The cerebral vasculature as a therapeutic target for neurological disorders and the role of shear stress in vascular homeostatis and pathophysiology
- 1 December 2004
- journal article
- review article
- Published by Taylor & Francis Ltd in Neurological Research
- Vol. 26 (8), 846-853
- https://doi.org/10.1179/016164104x3789
Abstract
It is widely accepted that vascular mechanisms are involved in the genesis of many neurological disorders. In particular, blood-brain barrier (BBB) dysfunction has been related to the severity of Alzheimer's disease, encephalopathy due to meningitis, multiple sclerosis, HIV-associated encephalopathy, epilepsy, gliomas and metastatic brain tumors. The BBB may constitute an important therapeutic target to protect neurons after CNS diseases. Both in vivo and in vitro, the functional phenotype of vascular endothelium is dynamically responsive to circulating cytokines, growth factors and puslatile blood flow (shear stress). Shear stress can play a critical role in vascular homeostasis and pathophysiology; it is a major regulator of remodeling in developed blood vessels and in blood vessels affected by atherosclerotic lesions. The physiological fluid mechanic stimulus, shear stress, could be considered to be an important 'differentiative' stimulus capable of modulating endothelial phenotype in vivo. Endothelial cells undergo cell cycle arrest after exposure to physiological levels of shear stress. As for mature endothelial cells, in which flow mediated shear stress may play a role in the induction, progression and/or prevention of atherosclerosis by changing their function, stress may play a role in endothelial cell differentiation from hemopoietic stem cells and/or from embryonic stem cells. Stem cells may be used to repair vascular damage, including loss of EC, due to a variety of diseases (e.g. myocardial neovascularization by adult bone marrow derived angioblasts). In the brain, it was proposed that neuron-producing stem cells may be used to treat Alzheimer's disease, paralysis, etc. Surprisingly, very few investigators are exploring the use of endothelial precursors to revert or prevent cerebrovascular disease. This review summarizes the most recent data related to cerebral vasculature as a therapeutic target for neurological disorders and the role of shear stress in blood-brain barrier homeostasis and pathophysiology.Keywords
This publication has 81 references indexed in Scilit:
- Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectorsGene Therapy, 2003
- Inflammatory Responses in the Cerebral Cortex After Ischemia in the P7 Neonatal RatStroke, 1999
- Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularizationJCI Insight, 1999
- Embryonic Stem Cell Lines Derived from Human BlastocystsScience, 1998
- Effects of Mechanical Forces on Signal Transduction and Gene Expression in Endothelial CellsHypertension, 1998
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996
- Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury.JCI Insight, 1996
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Reduction of Coronary Atherosclerosis by Moderate Conditioning Exercise in Monkeys on an Atherogenic DietThe New England Journal of Medicine, 1981